文献速递胃肠外科急腹症与外科感染

经肛结直肠管解除梗阻性结直肠癌的病理影响

Pathological impact of transanal colorectal tube for obstructive colorectal cancer.
PubMed 文献 · Surg Endosc · 2019-10-17

TCT组脓肿发生率显著低于手术组(11.6% vs 36.0%,P=0.017),病理穿孔有更低趋势(4.7% vs 20.0%,P=0.091),肿瘤学因素及炎性细胞因子基因表达无显著差异。提示TCT对肿瘤及周围组织无病理学损害。

要点

  • TCT组脓肿发生率显著低于急诊手术组(11.6% vs 36.0%,P=0.017)。
  • TCT组病理穿孔有更低趋势(4.7% vs 20.0%,P=0.091)。
  • 两组神经侵犯、微淋巴管及微血管侵犯等肿瘤学因素无显著差异。

核心结论

  • TCT置入对肿瘤及周围组织无病理学损害,可能成为远端梗阻性结直肠癌的非侵入性策略。

研究设计与样本

  • 比较急诊手术(25例)与TCT置入(43例)的病理炎症及恶性潜能相关参数,并由单盲病理学家分析。

主要发现

  • TCT组脓肿发生率显著低于手术组(11.6% vs 36.0%,P=0.017)。
  • TCT组病理穿孔有更低趋势(4.7% vs 20.0%,P=0.091)。
  • 两组神经侵犯(52.0% vs 62.8%,P=0.383)、微淋巴管侵犯(52.0% vs 58.1%,P=0.623)、微血管侵犯(32.0% vs 25.6%,P=0.570)无显著差异。
  • 两组IL-6、IL-8、IL-1β基因表达水平无显著差异(P=0.580、0.250、0.941)。

临床怎么用

  • 对于II/III期远端结直肠癌伴急性梗阻,TCT置入不增加病理损害,可作为急诊手术的替代选择。
  • TCT可能降低脓肿和病理穿孔风险,但需结合患者具体情况个体化决策。

局限性

  • 非随机分组,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Colorectal cancer (CRC) with acute colorectal obstruction (ACO) is an emergency. Transanal colorectal tube (TCT) use can be a safe single-stage surgery with laparoscopy-assisted colectomy; it offers long-term outcomes equivalent to emergency surgery for stage-II/III CRC with ACO. Self-expanding metallic stent use, another alternative, may have detrimental pathological and molecular effects, whereas the pathological impact of TCT placement remains unclear. We hypothesized that TCT placement might exert little damage on primary tumor. Hence, the current study analyzed the pathological impact of TCT placement for CRC with ACO compared to emergency surgery. METHODS: Data from consecutive patients with stage-II/III distal CRC with ACO who underwent surgery between January 2007 and December 2015 were retrospectively reviewed at two Japanese affiliate hospitals. Inflammatory and malignant potential-related parameters were analyzed by a single blinded pathologist. We extracted mRNA from tumor tissues to analyze inflammatory cytokines. RESULTS: Sixty-eight patients with stage-II/III distal CRC with ACO were identified (surgery: 25 patients; TCT: 43 patients). Baseline characteristics were well balanced between the two groups. TCT showed a significantly lower frequency of abscess (surgery vs TCT, 36.0% vs 11.6%; P = 0.017) and a lower tendency of pathological perforation (surgery vs TCT, 20.0% vs 4.7%, respectively; P = 0.091), compared to the surgery group. There were no significant intergroup differences in oncological factors, including perineural invasion (surgery vs TCT, 52.0% vs 62.8%; P = 0.383), microlymphatic involvement (surgery vs TCT, 52.0% vs 58.1%; P = 0.623), and microvascular involvement (surgery vs TCT, 32.0% vs 25.6%; P = 0.570). No significant intergroup differences were found in interleukin (IL)-6, IL-8, or IL-1β gene expression levels (P = 0.580, 0.250, 0.941). CONCLUSIONS: TCT placement had no pathologically detrimental effects on the tumor or surrounding tissues and might be an attractive non-invasive strategy for cases of curative distal CRC with ACO.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Okuda Y, Shimura T, Kato H, et al. Pathological impact of transanal colorectal tube for obstructive colorectal cancer. Surg Endosc. 2019. PMID: 31624940. doi:10.1007/s00464-019-07188-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。